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Abstract 
Age-related hearing impairment (ARHI) is the most common sensory impairment in the ageing 
population; a third of individuals are affected by disabling hearing loss by the age of 65. It causes social 
isolation, depression and has recently been identified as a risk factor for dementia. The genetic risk 
factors and underlying pathology of ARHI are largely unknown, meaning that targets for new therapies 
remain elusive, yet heritability estimates range between 35% and 55%. We performed genome-wide 
association studies (GWAS) for two self-reported hearing phenotypes, using over 250,000 UK Biobank 
(UKBB) volunteers aged between 40-69 years. Forty-four independent genome-wide significant loci 
(P<5E-08) were identified, considerably increasing the number of established trait loci. Thirty-four loci 
are novel associations with hearing loss of any form, and only 1 of the 10 known hearing loci has a 
previously reported association with an ARHI-related trait. Gene sets from these loci are enriched in 
auditory processes such as synaptic activities, nervous system processes, inner ear morphology and 
cognition, while genetic correlation analysis revealed strong positive correlations with multiple 
personality and psychological traits for the first time. Immunohistochemistry for protein localisation in 
adult mouse cochlea implicate metabolic, sensory and neuronal functions for NID2, CLRN2 and 
ARHGEF28. These results provide insight into the genetic landscape underlying ARHI, opening up 
novel therapeutic targets for further investigation. In a wider context, our study also highlights the 
viability of using self-report phenotypes for genetic discovery in very large samples when deep 
phenotyping is unavailable. 
Introduction 
ARHI is characterised by a non-syndromic bilateral, sensorineural hearing loss that progresses with 
increasing age and is an established risk factor for depression1–3 and dementia4–7 . Hearing loss was 
ranked fourth in the latest study into the Global Burden of Diseases8, yet hearing amplification devices 
are the only treatment option currently available for ARHI, representing an area of unmet clinical need. 
The economic burden of the condition is increasing in response to the growing size of the ageing 
population; a recent review highlighted the excess medical costs due to hearing impairment as $3.3-
$12.8 billion in the USA alone9.  
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ARHI is expected to be a highly genetically heterogeneous trait given that over 150 genetic loci have 
been identified in non-syndromic congenital hearing loss alone (https://hereditaryhearingloss.org/). 
Previous GWAS of ARHI related phenotypes have only identified a small number of promising 
candidate genes, though there has been poor replication of findings to date, possibly reflecting varied 
phenotyping methods and limited sample sizes10–19. Alternatively, it might suggest that the genetic 
contribution to ARHI has been overestimated. To date, five genomic loci have been significantly 
associated with ARHL in previous GWAS15,16,18 only two of which were replicated in independent 
population samples. Understanding the genetic aetiology of ARHI sheds light on the pathophysiology 
of the condition and ultimately facilitates the development of novel therapeutic or preventative 
interventions.  
Here, we conducted two large hearing GWAS with sample sizes of over 250,000 individuals using the 
self-reported hearing difficulty and hearing aid use of UKBB participants and refined our results using 
a combination of conditional analysis and replication analysis. In addition, we performed in silico 
functional annotation and in vivo expression analysis (see Figure 1 for study design) to understand the 
role of gene variants in the biological mechanisms of ARHI.  
Our aim was to identify the genetic components of adult hearing impairment in the UK population and 
provide insight into the pathology of ARHI and associated traits. 
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Subjects and methods 
Participants 
The sample used for this study consisted of individuals who participated in the UKBB study. The UKBB 
is a national resource, initially set up to study lifestyle and genetic factors affecting ageing traits with 
the aim of understanding and improving healthy ageing at a population level. Over 500,000 volunteers 
attended 23 assessment centres across the UK between 2007-2013 where they donated samples for 
genotyping, completed lifestyle questionnaires and have standard measurements taken. The UKBB 
resource is described extensively elsewhere20. 
The cohort used for discovery association analysis consisted of UKBB participants with ‘White British’ 
ancestry. The UKBB sample classification ‘White British’ is derived from both principal component 
(PC) analysis and self-declared ethnicity21. Samples with excess heterozygosity, excess relatedness and 
sex discrepancies were identified and removed prior to analysis, resulting in samples sizes of n 
=250,389 and n = 253,918 for hearing difficulty (HDiff) and hearing aid (HAid) use respectively. 
For replication analysis, we used the UKBB ethnic group ‘Caucasians’ (white non-British Europeans). 
To assign participants into discrete ancestry clusters, we used the 1st and 2nd PC vectors provided by 
UKBB. A k-means clustering algorithm was applied to generate clusters for each PC. We then combined 
cluster indices for the PCs (1.1, 1.2, …, 5.5), compared them against self-reported ancestry and assigned 
the ancestry group accordingly. If contradictory, the pairwise clusters took precedence over the self-
report grouping. 
Two samples were used for replication analysis, the English Longitudinal Study of Ageing (ELSA) and 
TwinsUK. They were selected as they comprise predominantly Northern European ancestry samples 
and include relevant questionnaire data. ELSA is a longitudinal study, consisting of around 12,000 
respondents from the Health Survey for England. Eight waves of data collection have been completed 
since 200222. TwinsUK is the largest adult twin registry in the UK and comprises over 13,000 healthy 
twin volunteers aged 16-98. Collection of data and biological materials commenced in 1992 and is 
ongoing. During study participation, twins regularly complete health and lifestyle questionnaires and 
attend for clinical evaluation23. 
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Phenotype definitions 
Two phenotypes were derived for this study; a phenotype representing self-reported hearing difficulty 
(HDiff) and a phenotype representing self-reported hearing aid use (HAid). Participants in the UKBB 
study completed a touchscreen questionnaire during their visit to the assessment centre, which included 
questions regarding hearing status. Participants were assigned case/control status based on their 
responses to questionnaire measures regarding hearing difficulty and hearing aid use. HDiff cases 
responded “Yes” to both of the questions “Do you have any difficulty with your hearing” and “Do you 
find it difficult to follow a conversation if there is background noise (such as TV, radio, children 
playing)?” HDiff controls were selected if their response to both of these questions was “No”.  
Participants with any other combination of responses were removed. In addition, HDiff controls aged 
<50 were removed from analysis, as were any controls that responded “Yes” to the question “Do you 
use a hearing aid most of the time?” HAid cases responded “Yes” to “Do you use a hearing aid most of 
the time?” and controls responded “No”. Details of how the UKBB phenotype was derived are displayed 
in  Figure S1. 
If participants answered the questionnaire twice, i.e. attended an assessment centre for a repeat visit, 
the answer at the second time point was used in analysis, in order to increase the mean age of the sample. 
To reduce the likelihood of including congenital forms of deafness, participants who selected ‘I am 
completely deaf’ in the UKBB questionnaire were excluded from analysis. Note that a further, objective 
measure of hearing, the speech reception threshold using the ‘Digits in Noise’ (DIN) protocol, was 
obtained from 160,955 of the UK Biobank participants.24,25 Preliminary heritability assessment of the 
DIN did not yield clear heritability or association with age and therefore it was not considered suitable 
for the present study. 
Questionnaire responses for the ELSA and TwinsUK replication samples were derived to obtain 
comparable phenotypes to the UKBB phenotype (Figure S1). For the ELSA sample, case/control 
phenotypes were derived from responses to questionnaire measures collected during study Wave 7. The 
HDiff phenotype was derived using responses from two questions; “Do you ever have any difficulties 
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with your hearing?” and “Do you find it difficult to follow a conversation if there is background noise, 
such as TV, radio or children playing (using a hearing aid as usual)?” Cases were defined as participants 
who responded “Yes” to both questions, and controls who responded “No” to both questions. As in the 
UKBB analysis, controls who reported hearing aid use or age <50 were removed, as were any cochlear 
implant users in the case or control samples. The HAid phenotype was derived using the question 
“Whether ever wears a hearing aid”; cases responded “Yes most of the time”, or “Yes some of the time” 
while controls responded “No”. During ELSA data processing, age was capped at 90 years, and thus 
individuals aged > 90 were reported to be 90 years of age. Resulting ELSA samples sizes for association 
analysis of these traits were HDiff  = 3545 and HAid = 4482. 
The TwinsUK phenotypes were likewise derived from responses to questions. HDiff cases responded 
either “Yes, diagnosed by doctor or health professional” or “Yes, not diagnosed by health professional” 
to the question “Do you suffer from hearing loss?” while controls responded “No”. HAid cases 
responded or indicated “Yes” to either of “Do you wear a hearing aid?” and ‘Wearing a hearing aid’. 
HAid controls responded “No”. As TwinsUK is a longitudinal study, a number of participants gave 
responses to the same questions on multiple occasions. The most recent response was included in 
analysis, unless the latest response indicated that hearing had improved. In this scenario, the participant 
was excluded. TwinsUK recruits adult twins aged over 18 years. Twins aged <40 were removed from 
analysis so that the lower age limit was comparable to the UKBB cohort. In order to retain the size of 
the TwinsUK sample and thus optimise power, controls aged <50 were not removed (as in the discovery 
HDiff UKBB analysis). Resulting Twins UK samples sizes for association analysis of these traits were 
HDiff  = 3636 and HAid  = 3435. 
Genotyping and imputation 
The ~500,000 samples in UKBB were genotyped on one of two arrays; 50,000 samples were genotyped 
on the Affymetrix UK BiLEVE Axiom array while the remaining ~450,000 were genotyped on the 
Affymetrix UK Biobank Axiom® array. The two arrays shared 95% coverage resulting in >800,000 
genotyped SNPs. Imputation was carried out centrally by UKBB, primarily using the HRC reference 
panel and IMPUTE226. SNPs which do not feature on this panel were imputed with the UK 10K and 
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1000G panel. Analysis in this study was conducted with version 3 of the UKBB imputed data with 
487,409 samples imputed and available for analysis following UKBB centrally performed QC filters. 
ELSA samples were genotyped at UCL Genomics in two batches using the Illumina HumanOmni 2.5M 
platform. Imputation was carried out centrally by ELSA with IMPUTE2, using the 1000 Genomes phase 
I data set27 (see Web Resources).   
Genotyping of TwinsUK was conducted with a combination of Illumina arrays; HumanHap300, 
HumanHap610Q, 1M-Duo and 1.2MDuo 1M. The imputation reference was 1000G Phase3 v5 
(GRCh37). 
Association analysis 
Discovery association analysis was performed using a linear mixed-effects model approach to test for 
association between imputed SNP dosages and the two traits. BOLT-LMM v.228 was used for the 
association analysis, which corrects for population stratification and within-sample relatedness. In 
addition, the analysis was adjusted for age, sex, UKBB genotyping platform and UKBB PCs1-10. For 
quality control, SNPs were filtered based on two thresholds: (1) minor allele frequency (MAF) > 0.01; 
and (2) INFO score > 0.7. By implementing a MAF cutoff of 0.01, we reduced the likelihood of 
including participants with forms of congenital deafness, as we only detected variants that occur at least 
in 1/100 participants, a higher frequency of variants than the frequency of congenital deafness. 
Individuals with < 98% genotype call rate were removed.  
Conditional and joint analysis  
Conditional and joint SNP analysis was performed to identify independent signals within highly 
associated regions, using GCTA-COJO29. This analysis requires the linkage disequilibrium reference 
sample, which was obtained by random selection of 10,000 individuals from the UKBB cohort with 
White British ancestry. The reference sample size was selected to maximise power based on previous 
data simulations29. The distance assumed for complete linkage equilibrium was 10Mb and a cut off 
value of R2=0.9 was used to check for collinearity between the selected SNPs and those to be tested. 
Alleles with a frequency difference >0.2 between the reference sample and GWAS sample were 
8 
 
excluded. Independent SNPs identified with GCTA-COJO were mapped to the nearest protein coding 
gene using variant effect predictor (VEP)30, genome build GRCh37. VEP was used to establish whether 
the SNP was in an exonic, intronic or intergenic region, and also the functional consequence of the 
variant at that position.  
LD Score regression  
Univariate linkage disequilibrium score regression (LDSC) was used to calculate whether inflated test 
statistics were likely due to the polygenic nature of the trait or confounding bias, by analysing the 
relationship between test statistic and LD31.  
We also performed genetic correlation analysis between the HDiff trait and 765 traits available for 
correlation analysis on LD hub31,32. To filter our results, we calculated a conservative significance 
threshold with a multiple-test correction (0.05/764, p = 6.5E-5) and selected those with a correlation 
(rg) >0.3 or < -0.3 to report in this study and grouped the remaining traits into five categories.  
Heritability estimates  
SNP heritability estimates for the two traits were calculated with BOLT-LMM (h2g). As HDiff and 
HAid are both qualitative traits, these estimates were recalculated to the liability scale. Sample and 
population prevalence were specified as the case prevalence in the analysed sample; HDiff at 0.35 and 
HAid at 0.052. SNP heritability was also calculated using a region-based approach with Heritability 
Estimation from Summary Statistics (HESS)33. SNP heritability was partitioned into 1702 
approximately independent loci (see Web Resources). The EUR 1000G reference panel was used for 
LD estimation (see Web Resources).  
Replication association analysis  
The lead SNPs for each locus identified with conditional analysis (Table 1) were tested for association 
with HDiff and HAid phenotypes in each of the three cohorts UKBB (white non-British Europeans), 
TwinsUK and ELSA. The UKBB white non-British sample was examined using the same protocol as 
the White British dataset described above, under the linear mixed-effects models method with BOLT-
LMM adjusting for age, sex, UKBB PCs 1-10 and genotyping platform. As BOLT-LMM is unsuitable 
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for analysis of samples with N<5000, alternative software was used for the TwinsUK and ELSA 
association analysis. The TwinsUK sample was analysed using a linear mixed-effects model regression 
adjusting for age and sex with GEMMA34,  the most suitable software for twins as it can control for 
family structure. For the ELSA sample, one of each pair of related individuals was excluded from 
analysis during central quality control checks at ELSA (relatedness was estimated in PLINK 1.935), and 
PLINK2 logistic regression was used to test for association in the ELSA sample, adjusting for age and 
sex. 
For SNPs significantly associated with hearing difficulty in the discovery, a fixed-effect inverse-
variance weighted meta-analysis was conducted using METAL36 version 2011-03-25 with the three 
samples: White non-British UKBB, ELSA and TwinsUK. BOLT-LMM does not report analysed 
sample size per SNP, so to obtain the weight of the UKBB replication sample per SNP, sample size was 
calculated from PLINK linear regression. 
A power calculation37 was performed for each independent locus analysed in the replication analysis 
(p<0.05 for both traits and p<0.0012 for HDiff and p<0.00714 for HAid, Table S1 and S2). 
Gene prioritization, pathway and tissue enrichment analysis 
Summary statistics from the UKBB HDiff trait were input for Functional Mapping and Annotation of 
Genome-wide Association Studies (FUMA38). Firstly, the SNP2GENE function was used to identify 
lead SNPs from HDiff analysis that reached a suggestive level of significance and were independent at 
r2<0.1. These identified lead SNPs were used to perform gene set enrichment analysis with ToppGene 
Suite39. 
Secondly, gene-set analysis was performed with MAGMA40 using all of the SNPs that were analysed 
in the HDiff discovery association analysis.  Here, SNPs were mapped to protein coding genes that were 
within 10kb of the SNP location.  The effects of multiple SNPs were combined to calculate the 
significance of an association of a gene with HDiff. These significantly associated genes were analysed 
for differential expression in 30 general tissue types.       
Mouse tissue preparation 
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Adult mouse cochleae were collected at p28-p30 from C57BL/6 mice, bred in an in-house facility. Mice 
were euthanised according to Schedule 1 procedures as described in United Kingdom legislation 
outlined in the Animals (Scientific Procedures) Act 1986. Dissected inner ears were fixed in 4% 
paraformaldehyde diluted in PBS for 1 hour at room temperature before being washed several times in 
PBS. They were then decalcified in 10% EDTA overnight at 4oC, before being separated from the 
vestibular system. Cochlea were mounted in 4% low-melting point agarose and sectioned on a 
Vibratome (1000 plus system, Intracel) at 200-µm intervals.  
Immunofluorescence  
Antibodies used to identify protein localisation in the organ of Corti were: anti-nidogen-2 (NID2) at a 
1:750 dilution (Ab14513, Abcam), anti-clarin-2 (CLRN2) at 1:1000 (HPA042407, Atlas Antibodies) 
and anti-rho guanine nucleotide exchange factor 28 (ARHGEF28) at 1:1000 (HPA037602, Atlas 
Antibodies). All were detected using of an isotype-specific Alexa Fluor 488 goat anti-rabbit secondary 
antibody (Santa Cruz Biotechnology). Antibodies were diluted in a goat blocking solution (4% triton, 
8% goat serum, 1g BSA, 50ml PHEM buffer) and sections were stained with primary antibodies 
overnight at 4oC. Following PBS washes, sections were incubated with the secondary antibody at 
1:1000 in darkness at room temperature for 2 hours. Phalloidin-Atto 647N to f-actin (Sigma-Aldrich, 
Gillingham, UK) and DAPI were added to the secondary antibody incubations at 1:1000 to stain hair 
cell stereocilia and DNA respectively. Samples were imaged using a Zeiss LSM 880 Airyscan 20x 
objective. 
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Results 
Phenotype Definition 
UKBB participants were categorised using a case-control design based on responses to questions 
regarding hearing difficulty (HDiff, n=498,281) and hearing aid use (HAid, n=316,629), (see methods 
and Figure S1 for details). Following quality control filters and selection of white British participants 
(described in methods), the final sample sizes used for association analyses were n=250,389 (87,056 
cases and 163,333 controls) for HDiff , and n=253,918 (13,178 cases and 240,740 controls) for HAid. 
Genome-wide Association analysis 
A linear mixed-effects model was used to test for association between 9,740,198 SNPs and the two 
hearing traits, using BOLT-LMM v.228, which corrects for population stratification and within sample 
relatedness. The studies identified 2,080 and 240 SNPs at genome-wide significance (P<5E-08) for 
HDiff and HAid analysis, respectively (Figure 2 and Figure S2). Conditional and joint analysis using 
GCTA-COJO29 identified that these SNPs represent 41 and seven independent loci associated with 
HDiff and HAid, respectively, including four loci common to both traits, thus resulting in 44 
independent loci overall.  
SNP heritability estimates for the two traits calculated with BOLT-LMM (h2g) were 0.117 ± 0.001 for 
HDiff and 0.029, ±.001 for HAid. Estimates recalculated to the liability scale are 0.19 and 0.13 for HDiff 
and HAid respectively. SNP heritability was also calculated using a region-based approach (Figure S3); 
one local heritability estimate was significant (Bonferroni corrected p<0.05 for 1702 loci) for HDiff, 
Chr5 base positions 71240456- 73759326, p= 1.16E-05. No regions were significant in HAid (Figure 
S3). The Variant Effect Predictor (VEP)30 was used to map independent lead SNPs to the nearest protein 
coding genes, using the GRCh37 genomic reference. Of 41 independent SNPs associated with HDiff, 
six variants lie in exons, four of which result in missense mutations in EYA4 (MIM: 603550), CDH23 
(MIM: 605516), KLHDC7B and TRIOBP (MIM: 609761), 21 SNPs lie within introns and 14 are 
intergenic (Table 1). Six of the independent SNPs associated with HAid reside in intronic regions and 
1 is intergenic. Two highly significant independent associations with HDiff are found within 100 kb of 
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the ARHGEF28 (MIM: 612790) gene, this locus is also highly associated with the HAid phenotype. 
Other gene loci common to both traits are NID2 (MIM: 605399), CTBP2 (MIM: 602619) and EYA4 
(see Figure S4 for locus plots). 
Replication analysis  
Replication was attempted for the lead SNPs (41 HDiff and 7 HAid) by meta-analysing three 
independent samples; the remaining Caucasians in the UKBB cohort (white, non-British Europeans), 
TwinsUK, and the English Longitudinal Study of Ageing (ELSA), totalling HDiff  n = 30,765 and HAid 
n = 35,004. Two intronic SNPs, rs759016271 in ZNF318 (MIM: 617512) and rs1566129 in NID2, 
reached significance in the HDiff replication analysis (Bonferroni correction 0.05/41=0.0012, 
P<0.0012), and a further intronic SNP, rs4597943 in ARHGEF28 replicated in HAid analysis at the 
significance threshold (0.05/7=0.00714, P<0.00714). An additional 14 SNPs reached nominal 
significance  and the power to detect each variant is also shown (Tables S1 and S2).  
We investigated whether any of the candidate genes identified in adult hearing in previously published 
genetic association studies were replicated within the discovery White British sample (Table 2) and 
found only two previous variant associations located in close proximity to ISG20 (MIM: 604533) and 
within TRIOBP, which were identified in a GWAS performed with data from electronic health records18. 
ISG20 is a novel association with hearing, but mutations in TRIOBP cause a form of autosomal 
recessive non-syndromic deafness, Deafness, autosomal recessive 28 (DFNB28, [MIM 609823]) 
41,42. No other lead variants from previous ARHI genetic studies were replicated at nominal level in our 
analysis, including the first reported ARHI associated gene variant in GRM711,13 (MIM: 604101).  
Gene prioritization, pathway and tissue enrichment analysis 
Functional gene annotation was undertaken with genes mapped from SNPs associated at a suggestive 
level (P<1E-05) in the HDiff association analysis (Figure 3). Genes were significantly enriched in a 
number of processes required for auditory function: synaptic activities, trans-synaptic signalling, 
nervous system processes, modulation of chemical synaptic transmission, positive dendritic spine 
morphogenesis, and inner ear morphology as well as cognition, learning or memory. These genes were 
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also significantly enriched with mouse phenotype ontologies, mostly relating to inner ear abnormalities 
and abnormal auditory brainstem response, and were significant at FDR 0.05 (Figure 3). As well as 
suggesting pathogenic pathways, this finding demonstrates the shared genetic pathology in mouse and 
human auditory systems, supporting the use of mouse models to study human auditory function. 
In silico tissue-specific gene expression analysis undertaken with MAGMA40 indicates a significant 
association between HDiff  genes and transcription levels of genes in the brain (P = 5.4E-04; Figure 
S5).  
LD Score Regression  
The LD score regression intercepts for the two analyses were 1.032 for HDiff and 1.03 for HAid. 
The ratio (intercept-1)/(mean(χ2)-1) for HDiff was 8% and represents the proportion of inflation in 
the χ2 statistic that the intercept attributes to alternative explanations than polygenicity. The ratio for 
HAid was 5%. We also performed genetic correlation analysis between HDiff and the 764 available 
traits on LDSC31. After removing the 3 traits that were used to create the HDiff and HAid phenotypes 
used in this study, 153 traits were significantly correlated with HDiff.  Here we have highlighted 41 
traits (significant correlation with HDiff and an rg< -0.3 or rg> 0.3) and grouped these into five 
categories; ‘Hearing’, ‘Low mood/depression’, ‘Pain’, ‘Breathing difficulties’ and ‘Health 
report/Subjective wellbeing’ (Table S3).  Regarding ‘Hearing’ traits, a strong positive correlation 
was observed between HDiff and self-reported tinnitus ‘Now or most of the time’ (rg = 0.6, SE 
0.056, p=1.40E-26). Traits in the Low mood/depression group included ‘frequency of 
tiredness/lethargy in last 2 weeks’ rg = 0.41, SE 0.029, p = 2.79E-45), neuroticism score (rg = 0.31, 
SE 0.026, p = 1.94E-34), miserableness (rg = 0.33, SE 0.027, p = 2.69E-33) and whether ‘seen doctor 
(GP) for nerves, anxiety, tension or depression’ (rg = 0.35 SE 0.03, p = 5.90E-31).  
Protein localisation of putative novel hearing genes  
We investigated expression of three putative novel hearing genes NID2, ARHGEF28 and CLRN2 in 
adult mouse cochlea using immunohistochemistry based on a number of factors. The lead SNP in NID2 
in both HDiff and HAid is located in intron 5 and was also replicated in the HDiff meta-analysis. Two 
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independent lead SNPs were identified at the ARHGEF28 locus in the HDiff analysis, along with a third 
SNP in the HAid analysis which replicated in the meta-analysis. The lead independent SNP at the 
CLRN2 locus in the HDiff analysis is within 2kb of CLRN2, although several other genes are within 
100kb. Because CLRN1 (MIM: 606397), a paralog of CLRN2, is expressed in hair cells and mutations 
in CLRN1 cause autosomal recessive Usher syndrome Type-3 (USH3, [MIM 276902]) with progressive 
sensorineural hearing loss,43,44 we investigated whether clarin-2 is also expressed in the inner ear. 
Immunostaining for nidogen-2, a basement membrane component encoded by NID2, was most 
prominent in the epithelial lining of the inner spiral sulcus between the tectorial membrane and the inner 
hair cell (Figure 4 and Figure S6), as well as localizing to nerve fibres and blood vessel basement 
membranes. Similar to clarin-1, clarin-2 immunostaining localised to the inner and outer hair cells, the 
primary sensory cells of sound detection (Figure 4 and Figure S6). ARHGEF28 encodes Rho Guanine 
Nucleotide Exchange Factor 28, for which immunostaining was observed in both hair cells and the 
spiral ganglion neuron cell bodies and axons (Figure 4 and Figure S6).  
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Discussion 
Using data from UKBB we have performed a GWASwith a sample size of over 250,000 individuals, 
identifying over 2,320 genome-wide significant SNPs, representing 44 independent associations with 
self-reported adult hearing loss in participants aged 40-69 years. Only one of these loci, TRIOBP has 
previously been associated with ARHI. Thirty-four of the loci are novel to hearing function while ten 
loci have previously been linked to some form of hearing loss either in mouse models or humans (Table 
1). Two independent associations were found within 100 kb of the ARHGEF28 locus. The findings 
represent a more than 400-fold increase in the number of reported genome-wide significant SNP 
associations and a nine-fold increase in independent genomic loci for ARHI-related phenotypes and 
provide a major breakthrough in revealing the genetic architecture of ARHI.  
Pure tone audiometry, the gold standard measure of hearing, requires an audiologist, a quiet 
environment and significant clinical time and is therefore challenging to collect in the large samples 
needed for GWAS. Due to this limitation previous GWAS in well characterised audiometric cohorts 
have included fewer than 5,000 cases. The most recent study, by Hoffmann et al. (2016)18 utilised ARHI 
related diagnoses in electronic health records to perform a larger study with 6,527 cases and 45,882 
controls and identified 2 genome wide significant SNPs. Our study is an order of magnitude larger than 
previous reported work using 87,056(HDiff) and 13,178 (HAid) cases with total sample sizes over 
250,000 for each trait. The increased sample size is achieved by utilising self–reported hearing data and 
self-report hearing aid use rather than using objective audiometric measures. The benefit of the 
increased power of this study is highlighted by the ability to detect a large number of associations by 
using self-report measures, as was previously demonstrated with another sensory trait45. 
Hearing aid users in the UK will have received a diagnosis of hearing impairment following a pure-tone 
audiometry test, and so this phenotype provides a good surrogate of abnormal pure tone audiometry. 
HDiff is a more subjective measure than would be provided by pure-tone audiometry and may well be 
influenced by psycho-social elements as well as hearing ability. However, it is known that a pure tone-
audiometry test does not diagnose all hearing loss including ‘hidden hearing loss’ (a key symptom of 
which is difficulty hearing with background noise present), meaning that HDiff may be more 
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representative of “real world” hearing impairment. Therefore, different forms of hearing loss may be 
defined by the two phenotypes, which may have subtle differences in pathology and genetic risk 
variants. In addition, within the UKBB sample hearing aid use is correlated with socio-economic status 
and education level46, providing evidence that environmental factors are associated with and may 
influence the UKBB phenotypes. These factors were not included as covariates for association analysis 
as the interaction with hearing loss is not currently fully understood.  
A long-standing question in ARHI has been whether the susceptibility genes for ARHI would be 
variants in known congenital deafness genes or completely novel genes.  Approximately one quarter of 
the genetic loci identified in the UKBB GWAS are known hearing loss genes while the rest are novel. 
For four of the 10 established hearing loci, this study provides the first link to hearing pathology in 
humans; BAIAP2L247 (MIM: 617536), TUB48 (MIM: 601197), SYNJ249 (MIM: 609410), and SPTBN150 
(MIM: 182790), as they have previously only been linked to hearing function in animal models. In 
addition, a number of these 10 loci have existing links to early onset, congenital deafness. CDH23 which 
encodes cadherin-23, is a component of the stereocilia tip link, deflection of which results in opening 
of the mechano-transduction necessary for sound detection51. It has long been proposed as a candidate 
human ARHI gene since an exon skipping mutation of cdh23 in the commonly used C57BL/6 strain of 
mice causes an accelerated age related hearing loss52. However, previous mutations in humans have 
been associated with a form of early onset recessive hearing loss, Deafness, autosomal recessive 12 
(DFNB12, [MIM 601386]) and with Usher’s syndrome type ID (USHID, [MIM 601067]) which causes 
early onset deafness and blindness53. This study provides a link between this locus and common adult 
hearing impairment, suggestive of multiple variants being present at the same loci but displaying 
different types of hearing phenotypes.  
Four significant gene loci are common to both analyses; EYA4, NID2, ARHGEF28 and CTBP2.  
Variants within EYA4 have been reported in autosomal dominant non-syndromic hearing loss54–56, 
Deafness autosomal dominant 10 (DFNA10, [MIM 601316]), while NID2 and ARHGEF28 are new 
associations with hearing impairment. CTBP2, though not previously linked to genetic risk of ARHI, 
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encodes C-terminal Binding Protein 2 a critical protein component of the inner ear hair cell pre-synaptic 
ribbon57.  The remaining loci were distinct between the two studies. 
SNP-based heritability recalculated to the liability scale for HDiff (19%) and HAid (13%) are at the 
mid-lower end of previous heritability estimates for ARHL58–60. This may be because this method 
only accounts for the additive genetic effects of the SNPs that were included in our analysis61. This 
sample is however larger than previous samples used for a heritability estimate of common adult 
hearing loss and the phenotype measures do differ to those used for previous estimates.  
Genetic correlation analysis revealed a link between genetic data for common adult hearing loss and 
depression-associated traits and pain related traits . Studies have reported numerous epidemiological 
links between these depressive symptoms and hearing loss1,2,62, but there is no evidence of a common 
genetic aetiology. This correlation and significance does not account for genetic confounding, 
meaning that intermediate factors could contribute or be causal of the correlations reported.  Due to 
the nature of these significantly correlated traits, the correlation may be confounded by general 
wellbeing. In addition, sampling bias may be present due to variability between studies such as trait 
and covariate categorisation and inclusion32.   
Gene set enrichment analysis using ToppGene contributed further evidence that this trait is highly 
polygenic and has a heterogeneous pathology. Genes and terms associated with HDiff were enriched 
for abnormal inner ear abnormality, synaptic function, cognition and abnormal neuron morphology. 
These findings indicate that genetic factors have a role in the common dysfunction of a range of 
mechanisms within the auditory system. Connecting pathogenic genetic variants to distinct mechanisms 
within the auditory system will enable us to better understand the biological relevance of an individual’s 
genetic risk for hearing loss, and also how individual subsystems are dysregulated in the ageing 
population. With the knowledge that certain gene groups have a role in particular cell or tissue types, 
studies can be targeted to a likely pathogenic location.  
Analysis using ToppGene also revealed HDiff gene sets overlap with those involved in ‘cognition’, 
providing evidence of a possible genetic role to the link between hearing loss and cognition phenotypes. 
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However, the finding from MAGMA analysis of a significant association between HDiff genes and 
transcription levels of genes in brain tissue does not necessarily confirm this finding or that these 
genes cause pathology in higher auditory systems with age. The results from these expression studies 
may simply reflect the fact that sensory cells of the inner ear are of neural origin, or that a substantial 
amount of neuronal tissue expression data is available in comparison to the limited datasets derived 
from cochlear tissue.  
Suggestive level associations between HDiff and mouse ontologies is a promising finding for the 
field. Phenotype driven screens in mice have been critically important in identifying deafness genes 
and are the model organism of choice for the study of hearing genetics, primarily due to the similarity 
of audiology systems and convergent evolution. However, there is less evidence that similar genetic 
predisposition to auditory ageing is comparable between mice and humans. These results, together 
with the identification of CDH23 as a human ARHI loci, supports the use of mouse models in genetic 
studies of ARHI.  
While Nidogen-2 is an established component of the basement membrane protein complex, anti-
NID2 staining was not observed in the basilar membrane of the organ of Corti. It was however 
observed staining the blood vessel basement membranes, as has been noted in other tissues 
previously63, providing evidence of antibody specificity in our sample. Anti-NID2 staining was most 
prominent in a restricted region of the epithelial lining between the inner spiral sulcus and spiral limbus 
suggesting it may have a role in maintaining the structure of the epithelia here in close proximity to the 
attachment site of the tectorial membrane.  
Similar to clarin-164, clarin-2 immunostaining localised to the inner and outer hair cells, the primary 
sensory cells of sound detection, suggesting it may have a similar role in hearing (Figure 4,Figure S5). 
During preparation of the manuscript recent evidence from concurrent studies suggests that mutations 
in clrn2 can cause progressive hearing loss in mouse and zebrafish and that mutations in CLRN2 
underlie a recessive form of congenital hearing loss in an Iranian family64,65. In addition to observing 
anti-ARHGEF28 staining in the sensory cells, anti-ARHGEF28 stains the lining of the nerve fibres in 
the SGN region. Previous reports demonstrate a role for ARHGEF28 in regulation of neurofilaments66,67 
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and axon growth and branching67. It has also been implicated in the pathogenesis of motor neuron 
disease through formation of neurofilament and ARHGEF28 aggregates68, perhaps implying a role in 
neuronal function or maintenance.  
Our study should be received in the context of its limitations; first, there is currently a lack of adequately 
powered studies with which to replicate our results. Despite meta-analysing three cohorts, the 
replication sample remains an order of magnitude smaller than the discovery set. It is therefore 
unsurprising that only three genes ZNF318, NID2 and ARHGEF28 were replicated. This replication rate 
likely reflects sample heterogeneity as well as ‘winner’s curse’70 . This heterogeneity includes varied 
questionnaire measures used to derive the phenotypes in the three replication samples and the different 
demographics of the individual cohorts. The lack of samples with consistent phenotype measures is a 
key limitation in genetic hearing research. One of the three cohorts included in our replication meta-
analysis is a subset of the UKBB cohort and therefore is not a truly independent sample from the 
discovery cohort. However, the identification of known hearing genes, gene annotation analysis and the 
results of in vivo expression provide support and putative mechanisms for involvement of these genes 
in hearing loss. 
Second, we could not confirm the age of onset of hearing difficulty or hearing aid prescription, making 
an accurate diagnosis of ARHI a challenge. Some of the associations, for example, may be driven by 
individuals with congenital hearing impairment due to highly penetrant variants. We reduced the 
likelihood of this by implementing a minor allele frequencycut-off of 0.01 (i.e., higher than the known 
frequency of variants involved in congenital deafness) and by excluding participants who selected ‘I 
am completely deaf’ in the UKBB questionnaire.  
In summary, we have conducted a GWAS on adult hearing using over 250,000 samples and have 
identified 44 associated independent loci. Several genes identified are known to have a role in 
congenital deafness, are already known to have an important role in hearing or have been identified in 
mouse models. One locus has been associated with human ARHI traits previously and 34 of the 44 loci 
identified have not previously been associated with hearing loss phenotypes in humans or mice. 
Interestingly, these genes have a range of biological functions and are suggestive of multiple pathogenic 
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pathways underlying ARHI and are not restricted to only one of sensory or neural or metabolic forms 
hearing loss. For three genes we demonstrate different localised cell specific expression within the 
mouse adult cochlea. Importantly, this study demonstrates that self-reported hearing loss in adults is 
suitable for use in association studies using large cohorts such as the UKBB. Our results present a 
framework for further study into the auditory pathways influenced by the genomic loci identified and 
provide therapeutic opportunities in ARHI and possibly dementia.
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Figure Titles and Legends 
Figure 1. Workflow schematic for discovery and validation of associated loci. N, sample size; QC, 
quality control; PC, principal components; MAF, minor allele frequency; INFO, quality metric, 
combination of imputation score and dosage confidence 
 
Figure 2. Manhattan plots displaying GWAS results for (A) Hearing difficulty, and (B) Hearing 
aid use phenotypes. The Manhattan plots display the P values of all SNPs tested in discovery analysis. 
The threshold for genome wide significance (p<5x10-8) is indicated by a red dotted line. Loci that 
reached genome-wide significance in both phenotypes are annotated with gene symbol. 
 
Figure 3. Heatmap of the enriched functional terms for genes mapped to lead SNP at suggestive 
level (HDiff analysis), using ToppGene Suite. Genes and functional terms were grouped using 
clustering of the strength of the enrichment of genes for respective functional terms. Functional terms 
include GO Biological Process, GO Molecular Function, GO Cellular Component, Mouse Phenotype, 
Pathway, and Disease. 
 
Figure 4. Cochlear expression of three putative hearing genes identified in HDiff and HAid 
GWAS. (A,B,C,D) Locus zoom plots of associated loci, generated with HDiff summary statistics. Four 
associated loci are plotted which have lead SNPs in or in proximity to ARHGEF28 (A,B), NID2 (C), 
and CLRN2 (D). Purple indicates lead independent SNP generated from GCTA-COJO conditional 
analysis. Colouring of remaining SNPs is based on linkage disequilibrium (LD) with the lead SNP. The 
genes within the region are annotated, and the direction of the transcripts is shown by arrows. Two 
independent regions were identified within the ARHGEF28 locus; both are shown. (E,F,G,H) 
Immunofluorescence images of adult mouse cochlea, spiral ganglion neurons (E) and organ of Corti (F-
H). Vibratome sections stained with the three proteins of interest in mouse inner ear; DAPI (blue) and 
Phalloidin (magenta) were also used for staining of actin and nuclei respectively. (E) Anti-ARHGEF28 
staining is observed in the neuronal cell bodies and axons. (F) Anti-ARHGEF28 (green) is mainly 
observed in outer and inner hair cells. (G) Anti-NID2 (green) staining is observed lining blood vessels 
and the epithelial lining of the inner spiral sulcus. (H) Anti-CLRN2 (green) staining is observed in outer 
and inner hair cells, in addition to the stria vascularis. The scale bar in image (G) represents 100µm. 
The scale is consistent for all images in this figure. 
 
Tables 
Table 1. Results output from BOLT-LMM and GCTA-COJO. Chr., chromosome; SNP, single 
nucleotide polymorphism; EA, effect allele; EAF, frequency of effect allele in BOLT-LMM; INFO, 
quality metric, combination of imputation score and dosage confidence; β, effect size from BOLT-
LMM approximation to infinitesimal mixed model; SE, standard error of the effect size; p-value, 
infinitesimal mixed-effects model association test p-value; pJ-value, p-value from a joint analysis of all 
the selected SNPs; Nearest Gene, protein-coding gene in closest proximity to SNP; Distance to gene 
(bp), distance in base pairs between SNP and nearest gene, a value of 0 indicates the SNP lies within 
the gene; Other genes within 100kb, list of genes within 100kb of the SNP. a denotes genes previously 
linked to hearing phenotypes in mice or humans. Two SNPs reached genome-wide significance in the 
HAid analysis that are in close proximity to HLA-DQA1 on Chr 6 (Figure 2) but were not present in 
conditional analysis results.    
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Table 1. Independent SNPs significantly associated (P<5 × 10−8) with the two phenotypes regarding hearing ability in the UK Biobank discovery sample.   
Hearing Difficulty GWAS 
Chr SNP EA  EAF INFO β SE p-value pJ-value Nearest Gene 
Distance 
to gene 
(bp) 
Other genes within 100kb 
22 rs36062310 G 0.96 1.000 -0.0315 0.003 1.90E-22 1.92E-22 KLHDC7B 0 
SYCE3, ADM2, ARSAa, CHKB, CPT1B, LMF2, MAPK8IP2, 
MIOX, NCAPH2, ODF3B, SBF1, SCO2, SYCE3, TYMP 
5 rs6453022 C 0.50 1.000 -0.0126 0.001 1.70E-21 2.07E-12 ARHGEF28 0 - 
6 rs759016271 
AGTAGTC
CACTTTT
CTTCTTT
GCCTG 
0.39 0.997 -0.0127 0.001 6.10E-21 6.16E-21 ZNF318 0 CRIP3, SLC22A7, CUL9, DNPH1, TTBK1 
5 rs6890164 A 0.51 0.993 0.0119 0.001 3.30E-19 4.15E-10 ARHGEF28 6177 - 
11 rs7951935 G 0.62 0.996 -0.0114 0.001 7.80E-17 7.85E-17 TYR 1472 NOX4 
6 rs35186928 G 0.62 0.991 -0.0109 0.001 1.70E-15 1.69E-15 HLA-DQA1 13352 HLA-DRB1, HLA-DRB3, HLA-DRB5, HLA-DRB6 
6 rs9493627 G 0.68 1.000 -0.0104 0.001 1.40E-13 1.41E-13 EYA4a 0 - 
22 rs132929 G 0.59 0.999 -0.0098 0.001 2.20E-13 4.61E-13 BAIAP2L2a 0 SLC16A8, PICK1 , PLA2G6, POLR2F 
22 rs5756795 T 0.54 1.000 -0.0092 0.001 5.10E-12 1.09E-11 TRIOBPa 0 
GALR3, GCAT, GGA1a, H1F0, LGALS1, NOL12, PDXP, 
SH3BP1 
14 rs1566129 T 0.41 1.000 0.0091 0.001 1.40E-11 1.37E-11 NID2 0 GNG2, RTRAF 
4 rs35414371 T 0.87 0.998 -0.0131 0.002 1.60E-11 1.64E-11 CLRN2a 1965 LAP3, MED28, QDPR 
3 
3:182069497_
TA_T 
TA 0.84 0.989 -0.0118 0.002 4.10E-11 4.07E-11 ATP11B 441791 - 
11 rs12225399 G 0.65 0.989 -0.009 0.001 8.60E-11 8.67E-11 PHLDB1 0 ARCN1, IFT46, KMT2A, TMEM25, TREH, TTC36 
11 rs55635402 A 0.81 0.996 0.0105 0.002 2.90E-10 2.94E-10 TUBa 0 EIF3F, NLRP10, OR10A3, RIC3 
16 rs62033400 A 0.61 0.999 0.0085 0.001 2.90E-10 2.95E-10 FTO 0 RPGRIP1L 
8 rs13277721 G 0.49 0.992 -0.0083 0.001 3.30E-10 3.35E-10 AGO2 0 PTK2 
2 rs62188635 C 0.45 0.988 0.0083 0.001 4.70E-10 4.72E-10 KLF7 50519 - 
6 rs2236401 C 0.49 0.997 -0.0081 0.001 9.30E-10 9.38E-10 SYNJ2a 0 SERAC1a, GTF2H5 
7 rs4947828 T 0.23 0.999 -0.0096 0.002 1.00E-09 1.02E-09 GRB10 0 - 
10 rs6597883 T 0.84 0.989 0.0111 0.002 1.00E-09 1.05E-09 CTBP2 0 - 
5 rs34442808 T 0.49 0.992 -0.008 0.001 1.30E-09 1.32E-09 MCTP1, SLF1 0 - 
10 rs835267 A 0.53 0.996 0.008 0.001 1.60E-09 1.58E-09 EXOC6 0 CYP26A1, CYP26C1 
10 rs4948502 T 0.57 0.995 0.0081 0.001 1.70E-09 5.63E-10 ARID5B 0 - 
10 rs10824108 G 0.42 0.999 -0.0079 0.001 3.00E-09 1.24E-08 ADK 0 AP3M1, VCL 
1 rs12027345 G 0.57 0.995 0.0079 0.001 3.60E-09 3.64E-09 MAST2 12668 GPBP1L1, MAST2, TMEM69, TMA16P2, GPBP1L1 
6 rs217289 G 0.56 0.992 -0.0078 0.001 4.90E-09 4.92E-09 SNAP91 0 - 
3 rs13093972 A 0.55 0.992 -0.0078 0.001 5.50E-09 5.56E-09 ZBTB20 121137 - 
15 rs62015206 C 0.41 1.000 -0.0078 0.001 7.70E-09 7.76E-09 MAPK6 15613 BCL2L10, GNB5 
5 rs10475169 A 0.88 1.000 -0.0117 0.002 9.30E-09 9.37E-09 IRX2 190445 - 
17 rs17671352 T 0.38 0.999 0.0078 0.001 1.00E-08 1.43E-08 ACADVL 0 
DVL2a, DLG4, ASGR1, CLDN7, CTDNEP1, EIF5A, ELP5, 
GABARAP, GPS2, NEURL4, PHF23, SLC2A4, YBX2 
1 rs7525101 C 0.56 1.000 -0.0075 0.001 1.50E-08 1.45E-08 LMX1Aa 61973 - 
17 rs12938775 G 0.50 1.000 0.0075 0.001 1.60E-08 2.25E-08 PAFAH1B1 0 CLUH, RAP1GAP2 
8 rs76837345 A 0.93 0.997 -0.0146 0.003 1.90E-08 1.95E-08 CHMP4C 0 IMPA1, SLC10A5, SNX16, ZFAND1 
6 rs9366417 G 0.26 0.993 0.0085 0.002 2.10E-08 2.12E-08 SOX4 291019 - 
8 rs3890736 G 0.63 0.993 -0.0077 0.001 2.20E-08 2.22E-08 GFRA2 15676 - 
10 rs143282422 G 0.99 1.000 -0.0349 0.006 2.40E-08 3.02E-08 CDH23a 0 C10orf105 
7 rs9691831 A 0.42 0.995 -0.0074 0.001 3.10E-08 3.11E-08 TMEM213 0 ATP6V0A4a , KIAA1549 
11 rs141403654 A 0.98 0.878 -0.0313 0.006 3.50E-08 3.53E-08 AGBL2 0 C1QTNF4, FNBP4, MTCH2 , NUP160 
18 rs4611552 T 0.78 0.995 -0.0089 0.002 3.60E-08 3.56E-08 CCDC68 9362 - 
13 rs12552 A 0.44 0.994 0.0073 0.001 4.80E-08 4.86E-08 OLFM4 0 - 
1 rs10927035 C 0.35 0.995 -0.0075 0.001 4.90E-08 4.89E-08 AKT3 0 SDCCAG8 
Hearing Aid GWAS 
Chr SNP EA   EAF INFO β SE p-value pJ-value Nearest Gene 
Distance 
to gene 
(bp) 
Other genes within 100kb 
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5 rs4597943 G 0.51 0.989 -0.0042 0.001 2.10E-11 2.09E-11 ARHGEF28 0 - 
2 rs9677089 A 0.75 0.989 -0.0046 0.001 2.00E-10 1.98E-10 SPTBN1a 0 - 
6 rs9321402 G 0.68 0.999 -0.0042 0.001 3.00E-10 3.02E-10 EYA4a 0 - 
14 rs1566129 T 0.41 1.000 0.0037 0.001 2.50E-09 2.53E-09 NID2 0 RTRAF 
3 rs3915060 C 0.27 0.983 0.004 0.001 9.70E-09 9.70E-09 ILDR1a 0 CD86, SLC15A2 
10 rs10901863 C 0.73 0.934 -0.004 0.001 2.60E-08 2.65E-08 CTBP2 0 - 
8 rs7823971 C 0.80 0.991 -0.0043 0.001 2.70E-08 2.68E-08 
RP11-
1102P16.1 
0 - 
31 
 
Table 2. Study, publication of previous finding; Gene, gene highlighted in the referenced publication as the lead SNP is either located in the gene region or in 
close proximity; SNP, single nucleotide polymorphism; CHR, Chromosome; BP, base position; A1, effect allele in analysis; A0, reference allele; INFO, quality 
metric, combination of imputation score and dosage confidence; UKBB phenotype, phenotype used in this study; A1FREQ, frequency of effect allele in analysis 
sample; BETA, effect size from BOLT-LMM approximation to infinitesimal mixed model; SE, standard error of the effect size; p-value, infinitesimal mixed 
model association test p-value. *This study did not analyse SNP rs58389158, but analysed rs5756795 which is in complete LD with this SNP in the British 
population, and referenced in the previous study.  
Table 2. Summary statistics from HDiff and HAid GWAS analysis, at SNPs highlighted in previous adult hearing loss GWAS. 
Variant highlighted in previous study Summary statistics from HDiff and HAid analysis in the UKBB cohort 
Citation Gene SNP CHR BP A1 A0 INFO UKBB Phenotype A1FREQ BETA SE P 
Friedman et. al 
200914 
GRM7 rs11928865 3 7155702 T A 0.989 
HDiff 0.741 0.0016 0.0015 0.28 
HAid 0.742 -0.0014 0.0007 0.05 
Van Laer et al., 
201012 
IQGAP2 rs457717 5 75920972 A G 0.986 
HDiff 0.326 0.0013 0.0014 0.34 
HAid 0.325 -0.0006 0.0007 0.37 
GRM7 rs161927 3 7838242 G A 0.988 
HDiff 0.134 0.0038 0.0019 0.05 
HAid 0.136 -0.0002 0.0009 0.86 
Girotto et al., 
201117 
DCLK1 rs248626 5 141097725 A G 1.000 
HDiff 0.251 0.0018 0.0015 0.23 
HAid 0.252 -0.0003 0.0007 0.71 
KCNMB2 rs4603971 3 177902467 G A 0.992 
HDiff 0.934 -0.0015 0.0027 0.58 
HAid 0.934 0.0006 0.0012 0.63 
CMIP rs898967 16 81566780 C T 0.981 
HDiff 0.476 0.0010 0.0013 0.45 
HAid 0.476 0.0002 0.0006 0.76 
GRM8 rs2687481 7 125869122 G T 0.998 
HDiff 0.811 -0.0018 0.0017 0.28 
HAid 0.810 0.0012 0.0008 0.14 
Nolan et al., 
201319 
ESSRG rs2818964 1 216682448 G A 0.978 
HDiff 0.366 -0.0015 0.0014 0.27 
HAid 0.366 0.0004 0.0006 0.55 
Wolber et al., 
201415 
SIK3 rs681524 11 116748314 T C 0.992 
HDiff 0.927 -0.0010 0.0026 0.71 
HAid 0.928 0.0018 0.0012 0.13 
Vuckovic et al., 
201516 
PCDH20 rs78043697 13 62467039 T C 0.995 
HDiff 0.928 0.0000 0.0025 1.00 
HAid 0.928 0.0010 0.0012 0.38 
SLC28A3 rs7032430 9 86714002 C A 0.959 
HDiff 0.782 -0.0013 0.0016 0.43 
HAid 0.783 -0.0001 0.0008 0.91 
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Fransen et al., 
201510 
ACVR1B rs2252518 12 52381026 C A 0.996 
HDiff 0.739 -0.0010 0.0015 0.50 
HAid 0.739 0.0001 0.0007 0.85 
CCBE1 rs34175168 18 57180682 G A 0.990 
HDiff 0.986 0.0112 0.0056 0.04 
HAid 0.986 -0.0009 0.0026 0.74 
Hoffman et al., 
201618 
ISG20 rs4932196 15 89253268 T C 1.000 
HDiff 0.809 0.0085 0.0017 4.60E-07 
HAid 0.809 0.0039 0.0008 6.40E-07 
TRIOBP rs5756795* 22 38122122 T C 1 
HDiff 0.539 -0.0092 0.0013 5.10E-12 
HAid 0.538 -0.0027 0.0006 1.60E-05 
 
 
 
Discovery analysis
9,740,198 SNPs, MAF > 0.01, INFO > 0.7
Analysis adjusted for age, sex, UKBB genotyping platform, UKBB PCs 1-10
Hearing difficulty 
N = 250,389
Genome-wide significance p< 5x10-8
Conditional analysis: 41 independent loci
GWAS of hearing impairment in the UKBB Cohort
Genotype QC
Omitted samples with high 
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In silico functional analysis
SNP-based analysis (VEP), Gene set enrichment analysis (ToppGene Suite), Gene-based analysis (MAGMA)
GWAS replication
Replication meta-analysis conducted in the remaining sample of Caucasians in the UKBB cohort (white non-
British), the English Longitudinal Study of Aging and TwinsUK
Hearing aid use
N = 253,918
Genome wide significance p< 5x10-8
Conditional analysis: 7 independent loci
Phenotypes used in GWAS analysis:
1. Hearing difficulty, HDiff
2. Hearing aid use, HAid
Phenotype generation specified in Figure S1
In vitro functional analysis
Protein localization in adult mouse cochlear with immunofluorescence
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